clarithromycin has been researched along with Grippe in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (36.84) | 29.6817 |
| 2010's | 11 (57.89) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Chi, H; Chiu, NC; Huang, CY; Huang, DT; Huang, FY; Huang, LM; Lee, CW; Tai, YL; Tu, YH; Wang, JY | 1 |
| Ishii, H; Ishimoto, H; Kadota, JI; Mukae, H; Nishida, C; Noguchi, S; Sakamoto, N; Umeki, K; Yamasaki, K; Yatera, K | 1 |
| Chan, KH; Hung, IFN; Kao, RYT; Lee, ACY; Li, C; To, KKW; Yuen, KY; Zhang, AJX; Zhang, RR; Zhu, H | 1 |
| Mazzetti, A; Neary, JD | 1 |
| Hung, IFN; Yuen, KY | 1 |
| Arai, M; Hirotsu, N; Iwaya, M; Kido, H; Mino, M; Mizuno, D; Nishikawa, K; Sawabuchi, T; Shibao, K; Shinahara, W; Shindo, S; Suzuki, S; Takahashi, E; Takasaki, Y; Yamashita, Y; Yokoyama, T | 1 |
| Akagawa, KS; Hirose, T; Kobayashi, K; Nagao, T; Nakayama, T; Ōmura, S; Oshima, M; Sugamata, R; Sugawara, A; Sunazuka, T; Suzuki, K; Yamamoto, K | 1 |
| Higashi, F; Kubo, H; Nukiwa, T; Yamaya, M; Yasuda, H | 1 |
| Gaüzère, BA; Malvy, D | 1 |
| Chan, JFW; Chan, KH; Chan, TC; Chen, H; Cheng, VCC; Cheung, MKS; Fok, M; Hung, IFN; Lau, JYN; Leung, W; Li, P; Liu, KSH; Tam, A; To, KKW; Wong, TL; Yuen, KY; Zhang, AJ; Zhang, R | 1 |
| Jongwutiwes, U; Leelarasamee, A; Puthavathana, P; Siritantikorn, S; Tantipong, H | 1 |
| Finley, R; Glass, SK; McEwen, SA; Pearl, DL | 1 |
| Chida, J; Ito, C; Iwase, K; Kido, H; Mizuno, D; Sawabuchi, T; Suzuki, S; Talukder, SR; Togari, H; Watanabe, I | 1 |
| Chojin, Y; Ishii, H; Kadota, J; Komiya, K; Mukae, H; Yamagata, E; Yamamoto, H; Yatera, K | 1 |
| Yamaya, M | 1 |
| Sato, K | 1 |
| Ninomiya, K | 1 |
| Shiroki, K | 1 |
| Kido, H; Le, TQ; Okumura, Y; Yamada, H; Yano, M | 1 |
2 review(s) available for clarithromycin and Grippe
| Article | Year |
|---|---|
[Recent topics on influenza].
Topics: Animals; Bronchoalveolar Lavage Fluid; Clarithromycin; Disease Outbreaks; Drugs, Chinese Herbal; Humans; Influenza, Human; Interleukin-12; Orthomyxoviridae | 2004 |
Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents.
Topics: Ambroxol; Animals; Antiviral Agents; Brain; Clarithromycin; Drug Therapy, Combination; Expectorants; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A virus; Influenza, Human; Neuraminidase; Peptide Hydrolases; Protease Inhibitors; Protein Processing, Post-Translational; Pulmonary Surfactants; Respiratory System; Secretory Leukocyte Peptidase Inhibitor; Virus Replication | 2007 |
3 trial(s) available for clarithromycin and Grippe
| Article | Year |
|---|---|
Additional treatment with clarithromycin reduces fever duration in patients with influenza.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Biomarkers; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Interleukin-6; Male; Middle Aged; Neuraminidase; Prospective Studies; Time; Treatment Outcome; Young Adult | 2014 |
Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Clarithromycin; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hospitalization; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Length of Stay; Male; Mortality; Naproxen; Nasopharynx; Oseltamivir; Severity of Illness Index; Treatment Outcome; Viral Load | 2017 |
[Beneficial effects of macrolide antibiotics on children with influenza].
Topics: Adolescent; Bacteria; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Infant; Influenza, Human; Male; Pharynx; Pneumonia, Bacterial; Treatment Outcome | 2003 |
14 other study(ies) available for clarithromycin and Grippe
| Article | Year |
|---|---|
Efficacy of clarithromycin-naproxen-oseltamivir combination therapy versus oseltamivir alone in hospitalized pediatric influenza patients.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Hospitalization; Hospitals, Pediatric; Humans; Infant; Influenza, Human; Male; Naproxen; Oseltamivir; Prospective Studies; Single-Blind Method; Treatment Outcome; Viral Load | 2021 |
The additive effect of clarithromycin on influenza A infection in the elderly patients and patients with comorbid diseases.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiviral Agents; Clarithromycin; Cohort Studies; Comorbidity; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Influenza A virus; Influenza, Human; Male; Middle Aged; Neuraminidase; Oseltamivir; Phosphorous Acids; Pneumonia; Prospective Studies; Treatment Outcome; Zanamivir | 2017 |
Triple combination of FDA-approved drugs including flufenamic acid, clarithromycin and zanamivir improves survival of severe influenza in mice.
Topics: Animals; Antiviral Agents; Clarithromycin; Drug Approval; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Flufenamic Acid; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Interleukin-1beta; Lung; Mice; Mice, Inbred BALB C; Tumor Necrosis Factor-alpha; United States; United States Food and Drug Administration; Zanamivir | 2018 |
Outcome Switching in Triple Therapy in Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial.
Topics: Clarithromycin; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Naproxen; Oseltamivir | 2018 |
Response.
Topics: Clarithromycin; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Naproxen; Oseltamivir | 2018 |
Immunomodulator clarithromycin enhances mucosal and systemic immune responses and reduces re-infection rate in pediatric patients with influenza treated with antiviral neuraminidase inhibitors: a retrospective analysis.
Topics: Adjuvants, Immunologic; Antiviral Agents; Child; Clarithromycin; Humans; Immunity, Mucosal; Influenza, Human; Neuraminidase; Retrospective Studies | 2013 |
Leucomycin A3, a 16-membered macrolide antibiotic, inhibits influenza A virus infection and disease progression.
Topics: Animals; Antiviral Agents; Cell Line, Tumor; Clarithromycin; Cytokines; Disease Models, Animal; Disease Progression; Drug Design; Epithelial Cells; Erythromycin; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Josamycin; Lung; Mice; Mice, Inbred BALB C; Neutrophils; Peroxidase; Spiramycin; Survival Rate | 2014 |
[Vingt-cinquième réunion du comité local de la Société de pathologie exotique, 24 novembre 2015].
Topics: Clarithromycin; Drug Resistance, Microbial; Guinea; Helicobacter Infections; Hemorrhagic Fever, Ebola; Histoplasmosis; Hospitalization; Humans; Influenza, Human; Leprosy; Otorhinolaryngologic Neoplasms; Reunion; Severity of Illness Index; Tropical Medicine | 2016 |
Fulminating influenza pneumonia in the elderly: a case demonstration.
Topics: Age Factors; Aged, 80 and over; Anti-Bacterial Agents; Antiviral Agents; Clarithromycin; Humans; Influenza A virus; Influenza, Human; Male; Oseltamivir; Pneumonia, Viral | 2008 |
Canadian province-level risk factor analysis of macrolide consumption patterns (2000-2006).
Topics: Anti-Bacterial Agents; Azithromycin; Canada; Clarithromycin; Drug Utilization; Erythromycin; Health Knowledge, Attitudes, Practice; Humans; Influenza, Human; Macrolides; Risk Factors; Seasons; Socioeconomic Factors | 2010 |
Boost of mucosal secretory immunoglobulin A response by clarithromycin in paediatric influenza.
Topics: Adolescent; Anti-Bacterial Agents; Antiviral Agents; Child; Child, Preschool; Clarithromycin; Cough; Drug Therapy, Combination; Humans; Immunoglobulin A; Infant; Influenza A virus; Influenza, Human; Nasal Mucosa; Oseltamivir; Prevalence; Retrospective Studies; RNA, Viral; Treatment Outcome | 2009 |
Clarithromycin has limited effects in non-elderly, non-severe patients with seasonal influenza virus A infection.
Topics: Adult; Antiviral Agents; Clarithromycin; Female; Humans; Influenza A virus; Influenza, Human; Male; Pneumonia; Treatment Outcome; Young Adult | 2012 |
[Effects of macrolides in preventing influenza and airway inflammation].
Topics: Clarithromycin; Erythromycin; Humans; In Vitro Techniques; Inflammation; Influenza A virus; Influenza, Human; Macrolides; Respiratory Mucosa | 2009 |
[Macrolide therapy of influenza and xanthine oxidase].
Topics: Clarithromycin; Humans; Influenza, Human; Macrolides; Oxidative Stress; Superoxides; Xanthine Oxidase | 2009 |